ParkerVision Resale Prospectus Updated with Q2 10-Q: $2.5M Cash, Going Concern, Patent Setbacks
PRKR is trading near its 52-week low of $0.07 (14% above the low).
Summary
ParkerVision's latest prospectus supplement attaches its Q2 2026 10-Q, disclosing a $2.5 million cash balance, a going concern warning, and patent litigation setbacks, while 16.6 million shares remain registered for resale by selling stockholders.
Key Events · Financing and Capital Events · PRKR
-
Q2 10-Q Attached
The attached 10-Q reports a $1.4M net loss for H1 2026, ending with $2.5M in cash and a going concern warning.
-
Patent Litigation Setbacks
Trials against MediaTek and Realtek were postponed; PTAB ruled key patents unpatentable in multiple IPRs, with appeals ongoing.
-
Resale Overhang
16.6 million shares registered for resale by selling stockholders at a fixed conversion price of $0.13, well above the current $0.08 stock price.
-
Shelf Registration Lost
The company no longer meets market cap eligibility requirements for its $25M shelf registration, cutting off a key funding source.
Analysis · PRKR · Manufacturing
This prospectus supplement attaches ParkerVision's Q2 2026 10-Q, revealing a cash balance of just $2.5 million, a going concern warning, and major setbacks in its patent litigation campaigns. The 16.6 million shares registered for resale by selling stockholders represent a significant overhang on a stock trading at $0.08, and the company's shelf registration is no longer usable. The combination of severe financial distress and potential selling pressure makes this a critical update for existing shareholders.
At the time of this filing, PRKR was trading at $0.08 on OTC in the Manufacturing sector, with a market capitalization of approximately $11.3M. The 52-week trading range was $0.07 to $0.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.